Farallon Capital Management LLC Portfolio Holdings

Farallon Capital Management LLC

  • $18.8 Billion
  • Q4 2024

Farallon Capital Management LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $18.8 Billion distributed in 138 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Exelixis, Inc. with a value of $781M, Unitedhealth Group Inc with a value of $740M, Natera, Inc. with a value of $702M, Microsoft Corp with a value of $688M, and Aon PLC with a value of $658M.

Examining the 13F form we can see an decrease of $526B in the current position value, from $544B to 18.8B. Also it can be appreciated an additional of 22 stocks purchases and 2 closed positions.

Farallon Capital Management LLC is based out at San Francisco, CA

Below you can find more details about Farallon Capital Management LLC portfolio as well as his latest detailed transactions.

Portfolio value $18.8 Billion
Healthcare: $7.27 Billion
ETFs: $3.75 Billion
Technology: $2.51 Billion
Financial Services: $1.55 Billion
Industrials: $1.47 Billion
Communication Services: $1.27 Billion
Consumer Defensive: $354 Million
Consumer Cyclical: $319 Million
Other: $286 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.64B
$12.5 Million 0.07% of portfolio
555,000
Q4 2024 New
$553M
$13.9 Million 0.07% of portfolio
1,000,981
Q4 2024 New
$3.42B
$11.7 Million 0.06% of portfolio
150,000
Q3 2024 New
$2.11B
$11.8 Million 0.06% of portfolio
628,800
Q4 2024 New
$166M
$12.1 Million 0.06% of portfolio
2,108,262
Q3 2024 Added 0.63%
$36.4M
$5.72 Million 0.03% of portfolio
3,811,426
Q4 2024 Reduced 17.8%
$725M
$5.4 Million 0.03% of portfolio
229,121
Q4 2024 Reduced 46.47%
$2.16B
$3.08 Million 0.02% of portfolio
650,000
Q1 2024 Reduced 63.38%
$1.5B
$2.57 Million 0.01% of portfolio
48,000
Q4 2024 New
$337M
$1.65 Million 0.01% of portfolio
150,000
Q4 2023 New
$5.75B
$1.02 Million 0.01% of portfolio
3,319
Q4 2023 New
$3.05B
$2.64 Million 0.01% of portfolio
199,675
Q3 2024 New
$14.2M
$2.05 Million 0.01% of portfolio
3,527,482
Q3 2024 Reduced 1.97%
$284M
$2.19 Million 0.01% of portfolio
750,000
Q1 2024 New
$2.62B
$147,000 0.0% of portfolio
11,000
Q1 2024 New
Zto Express Cayman Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 26.76%
Summit Midstream Corporation
-
$0 0.0% of portfolio
-
Q3 2024 New
Zymeworks Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 2.28%
$3.67B
$242,000 0.0% of portfolio
14,000
Q4 2023 New
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
$0
$170,000 0.0% of portfolio
405,316
Q4 2023 New
Revolution Medicines Inc
-
$0 0.0% of portfolio
-
Q4 2023 New
$434M
$232,000 0.0% of portfolio
42,800
Q4 2023 New
Tectonic Therapeutic Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 37.02%
Waystar Hldg Corp
-
$0 0.0% of portfolio
-
Q4 2024 New
$16.4B
$352,000 0.0% of portfolio
1,000
Q3 2024 Reduced 99.3%
Nvni Group Limited
-
$0 0.0% of portfolio
-
Q4 2023 New
$2.33B
$355,000 0.0% of portfolio
7,650
Q4 2024 Reduced 97.75%
$625M
$128,000 0.0% of portfolio
16,000
Q3 2024 Reduced 95.76%
$1.95B
$302,000 0.0% of portfolio
7,000
Q4 2024 New
$927M
$132,000 0.0% of portfolio
10,000
Q4 2023 New
$346M
$247,000 0.0% of portfolio
135,000
Q2 2024 Reduced 96.42%
$2.14B
$310,000 0.0% of portfolio
18,000
Q4 2024 Reduced 98.07%
$7.52B
$437,000 0.0% of portfolio
37,000
Q3 2024 Reduced 94.5%
Aleanna Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
$7.53B
$293,000 0.0% of portfolio
5,000
Q4 2024 Reduced 84.38%
$147M
$100,000 0.0% of portfolio
28,000
Q1 2024 New
Canopy Growth Corp
-
$0 0.0% of portfolio
-
Q2 2024 New
Cara Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
$0
$49,000 0.0% of portfolio
175,000
Q4 2023 New
$38.4B
$185,000 0.0% of portfolio
1,000
Q4 2024 Reduced 99.57%
$8.14B
$211,000 0.0% of portfolio
400
Q4 2023 New
$526M
$132,000 0.0% of portfolio
17,000
Q3 2024 Reduced 96.0%
$45.3B
$222,000 0.0% of portfolio
3,000
Q4 2024 New
$5.22B
$193,000 0.0% of portfolio
16,000
Q3 2024 New
Brightspring Health Svcs Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
$5.51B
$348,000 0.0% of portfolio
4,000
Q4 2023 New
Aleanna Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
$315M
$198,000 0.0% of portfolio
27,600
Q2 2024 Reduced 94.13%

Summary

  • Portfolio
  • No. of Stocks 138
  • Current Value $18.8 Billion
  • Prior Value $544 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 22 stocks
  • Additional Purchases 27 stocks
  • Sold out of 2 stocks
  • Reduced holdings in 31 stocks
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email